Anand Rathi Recommends Buying Max Healthcare, Sets Rs 1,200 Target
Anand Rathi's research report cites Max Healthcare's second-quarter FY27 revenue and EBITDA growth of 18% year over year, while profit after tax fell 20%.
Anand Rathi's research report cites Max Healthcare's second-quarter FY27 revenue and EBITDA growth of 18% year over year, while profit after tax fell 20%.